Literature DB >> 16105945

Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades.

Ayala Hezi-Yamit1, Paul W Wong, Nga Bien-Ly, Laszlo G Komuves, K S Srinivasa Prasad, David R Phillips, Uma Sinha.   

Abstract

Enzymes of the blood coagulation pathway enhance the inflammatory response leading to endothelial dysfunction, accounting, in part, for the vascular complications occurring in sepsis and cardiovascular disease. The responses of endothelial cell activation include induction of the expression of tissue factor (TF), a membrane glycoprotein that promotes thrombosis, and of E-selectin, a cell adhesion molecule that promotes inflammation. In this report, we demonstrate synergistic interactions between the coagulation factor Xa (fXa) and the proinflammatory cytokines TNF, IL-1beta, and CD40L, leading to enhanced expression of TF and E-selectin in endothelial cells. A detailed analysis of the molecular pathways that could account for this activity of fXa showed that fXa inhibited the cytokine-induced expression of dual specificity phosphatases, MAP kinase phosphatase-L, -4, -5, and -7, blocking a negative regulatory effect on c-Jun N-terminal kinase. The synergistic interaction between fXa and TNF was also involved in the inhibition of A20 and IkappaBalpha expression in the IkappaB kinase-NF-kappaB pathway. The data indicate that inhibition of negative regulatory signaling accounts for the amplification of cytokine-induced endothelial cell activation by fXa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105945      PMCID: PMC1189324          DOI: 10.1073/pnas.0504526102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases.

Authors:  A Theodosiou; A Smith; C Gillieron; S Arkinstall; A Ashworth
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

Review 3.  Thrombin-directed inhibitors: pharmacology and clinical use.

Authors:  C Michael White
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

Review 4.  Dual specificity phosphatases: a gene family for control of MAP kinase function.

Authors:  M Camps; A Nichols; S Arkinstall
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

5.  Inhibition of factor Xa by a peptidyl-alpha-ketothiazole involves two steps. Evidence for a stabilizing conformational change.

Authors:  A Betz; P W Wong; U Sinha
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

6.  The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling.

Authors:  T P Shanley; N Vasi; A Denenberg; H R Wong
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

Review 8.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.

Authors:  R Beyaert; K Heyninck; S Van Huffel
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

9.  Delayed onset of inflammation in protease-activated receptor-2-deficient mice.

Authors:  J R Lindner; M L Kahn; S R Coughlin; G R Sambrano; E Schauble; D Bernstein; D Foy; A Hafezi-Moghadam; K Ley
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

10.  Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.

Authors:  M A Cunningham; E Rondeau; X Chen; S R Coughlin; S R Holdsworth; P G Tipping
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  20 in total

1.  Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.

Authors:  Janka Reimer; Sandra Bien; Sabine Ameling; Elke Hammer; Uwe Völker; Georg Hempel; Joachim Boos; Heyo K Kroemer; Christoph A Ritter
Journal:  Eur J Clin Pharmacol       Date:  2012-06       Impact factor: 2.953

2.  Gene expression profiling of long-term changes in rat liver following burn injury.

Authors:  Arul Jayaraman; Tim Maguire; Murali Vemula; Deukwoo W Kwon; Marina Vannucci; Francois Berthiaume; Martin L Yarmush
Journal:  J Surg Res       Date:  2007-08-28       Impact factor: 2.192

Review 3.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 4.  The roll of Toll-like receptors in the antiphospholipid syndrome.

Authors:  Julia Hurst; Mareike Lorenz; Nadine Prinz; Philipp von Landenberg
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

5.  Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.

Authors:  Rashmi Sood; Shawn Kalloway; Alan E Mast; Cecilia J Hillard; Hartmut Weiler
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

6.  Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.

Authors:  I M B Francischetti; K B Seydel; R Q Monteiro; R O Whitten; C R Erexson; A L L Noronha; G R Ostera; S B Kamiza; M E Molyneux; J M Ward; T E Taylor
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

7.  Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Authors:  Jakub Swadzba; Teresa Iwaniec; Jacek Musial
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

Review 8.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

9.  Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels.

Authors:  Said El Shamieh; Ndeye Coumba Ndiaye; Maria G Stathopoulou; Helena A Murray; Christine Masson; John V Lamont; Peter Fitzgerald; Athanase Benetos; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

10.  Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.

Authors:  Qianxing Zhou; Florian Bea; Michael Preusch; Hongjie Wang; Berend Isermann; Khurrum Shahzad; Hugo A Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2011-06-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.